Press Release

Teva to Present at the UBS Global Life Sciences Conference

Jerusalem, Israel, September 17, 2009 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the UBS Global Life Sciences Conference with William Marth, President and Chief Executive Officer, Teva North America presenting on Wednesday, September 23, 2009, in New York.

What: Teva Presentation at the UBS Global Life Sciences Conference

Who: William Marth, President and Chief Executive Officer, Teva North America

When: Wednesday, September 23, 2009 at 10:00 a.m. ET

Where: http://cc.talkpoint.com/ubsx001/092109a_ke/?entity=28_86B3RLL
or http://www.tevapharm.com/financial/

How: Live over the Internet -- log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.

About Teva
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company. The Company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Over 80 percent of Teva's sales are in North America and Europe.

Company Contacts:

Elana Holzman
Kevin Mannix
Teva Pharmaceutical Industries Ltd.
Teva North America
972 (3) 926-7554
(215) 591-8912